Alivus Life Sciences Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is DAPAGLIFLOZIN AMORPHOUS, with a corresponding US DMF Number 31284.
Remarkably, this DMF maintains an Active status since its submission on January 31, 2017, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 06, 2017, and payment made on February 10, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II